Abbott Laboratories (ABT) Stock Price

ABTStockS&P 500
$104.89−17.82%52W
Market Cap$182.70B
P/E27.82x
PEG Ratio1.92
Div yield1.98%
Beta0.55

ABT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-6.11%
Price vs S&P 500 (4W)3.18%
PEG Ratio1.92
VGM Score53.65
P/E Ratio (Annual)27.82x
Indicated Dividend Yield (Annual)1.98%

ABT Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$1.28$1.31+2.61%(+$0.03)
Q1 2026$1.15$1.15+0.33%(+$0.00)
Q4 2025$1.49$1.50+0.34%(+$0.01)
Q3 2025$1.30$1.30+0.05%(+$0.00)

ABT Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.00
4.03
4.06
4.12

Industry Peers — Pharmaceuticals(574)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth TTM (YoY)Gross Margin (TTM)EPS Growth (5Y)Price
ABTAbbott Laboratories
CCB3.9x8.1%56.8%8.2%$104.89
LLYEli Lilly & Co.DBA14.9x49.6%83.4%27.6%$1257.03
JNJJohnson & JohnsonDCB6.2x7.8%67.7%14.9%$255.56
ABBVABBVIE INC.DCA7.8x10.4%72.8%-2.9%$285.42
MRKMerck & Co., Inc.DCA5.4x4.6%77.3%21.2%$145.95
NVSNovartis AGCCB4.9x3.3%75.0%15.3%$150.62
AZNAstraZeneca PLCCBB4.3x8.6%81.3%21.9%$165.41
NVONovo-Nordisk A/SBCC3.5x5.6%80.7%20.7%$38.83
PFEPfizer Inc.CDA2.6x-0.2%74.7%-3.5%$29.58
VRTXVertex Pharmaceuticals IncDCB10.1x10.2%86.0%8.3%$499.74
BMYBristol-Myers Squibb Co.BBB2.5x3.1%71.7%—$59.75

About Abbott Laboratories

Abbott is a diversified healthcare company with leading products in cardiovascular devices, diabetes care, diagnostics, and nutrition. The company manufactures pacemakers, defibrillators, continuous glucose monitors, diagnostic testing equipment, and infant nutritional products. Approximately 60% of sales come from international markets, providing significant geographic diversification.